265 related articles for article (PubMed ID: 25794984)
1. Effects of sitagliptin on coronary atherosclerosis evaluated using integrated backscatter intravascular ultrasound in patients with type 2 diabetes: rationale and design of the TRUST study.
Nozue T; Fukui K; Koyama Y; Fujii H; Kunishima T; Hikita H; Hibi K; Miyazawa A; Michishita I
Heart Vessels; 2016 May; 31(5):649-54. PubMed ID: 25794984
[TBL] [Abstract][Full Text] [Related]
2. Effect of sitagliptin on plaque changes in coronary artery following acute coronary syndrome in diabetic patients: The ESPECIAL-ACS study.
Kuramitsu S; Miyauchi K; Yokoi H; Suwa S; Nishizaki Y; Yokoyama T; Nojiri S; Iwabuchi M; Shirai S; Ando K; Okazaki S; Tamura H; Watada H; Daida H
J Cardiol; 2017 Jan; 69(1):369-376. PubMed ID: 27641967
[TBL] [Abstract][Full Text] [Related]
3. Effects of sitagliptin on coronary atherosclerosis in patients with type 2 diabetes-A serial integrated backscatter-intravascular ultrasound study.
Nozue T; Fukui K; Koyama Y; Fujii H; Kunishima T; Hikita H; Hibi K; Miyazawa A; Michishita I;
Am J Cardiovasc Dis; 2016; 6(4):153-162. PubMed ID: 28078175
[TBL] [Abstract][Full Text] [Related]
4. Sitagliptin attenuates the progression of coronary atherosclerosis in patients with coronary disease and type 2 diabetes.
Li B; Luo YR; Tian F; Chen YD; Tian JW; Ding Y; Zhu M; Li JW; Zhang YQ; Shi WM
Atherosclerosis; 2020 May; 300():10-18. PubMed ID: 32247073
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy of eicosapentaenoic acid and pitavastatin for coronary plaque regression evaluated by integrated backscatter intravascular ultrasonography (CHERRY study)-rationale and design.
Watanabe T; Miyamoto T; Miyasita T; Shishido T; Arimoto T; Takahashi H; Nishiyama S; Hirono O; Matsui M; Sugawara S; Ikeno E; Miyawaki H; Akira F; Kubota I
J Cardiol; 2014 Sep; 64(3):236-9. PubMed ID: 24503140
[TBL] [Abstract][Full Text] [Related]
6. Effects of alogliptin on fractional flow reserve evaluated by coronary computed tomography angiography in patients with type 2 diabetes: Rationale and design of the TRACT study.
Nozue T; Fukui K; Takamura T; Sozu T; Hibi K; Kishi S; Michishita I
J Cardiol; 2017 Mar; 69(3):518-522. PubMed ID: 27236239
[TBL] [Abstract][Full Text] [Related]
7. Effect of sitagliptin on tissue characteristics of the carotid wall in patients with type 2 diabetes: a post hoc sub-analysis of the sitagliptin preventive study of intima-media thickness evaluation (SPIKE).
Katakami N; Mita T; Irie Y; Takahara M; Matsuoka TA; Gosho M; Watada H; Shimomura I;
Cardiovasc Diabetol; 2018 Feb; 17(1):24. PubMed ID: 29402270
[TBL] [Abstract][Full Text] [Related]
8. Coronary plaque progression of non-culprit lesions after culprit percutaneous coronary intervention in patients with moderate to advanced chronic kidney disease: intravascular ultrasound and integrated backscatter intravascular ultrasound study.
Kashiyama K; Sonoda S; Muraoka Y; Suzuki Y; Kamezaki F; Tsuda Y; Araki M; Tamura M; Takeuchi M; Abe H; Okazaki M; Fujino Y; Otsuji Y
Int J Cardiovasc Imaging; 2015 Jun; 31(5):935-45. PubMed ID: 25724567
[TBL] [Abstract][Full Text] [Related]
9. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
Antonsen L; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Kaltoft A; Hansen HS; Thuesen L; Lassen JF; Jensen LO
Catheter Cardiovasc Interv; 2014 May; 83(6):864-72. PubMed ID: 23996918
[TBL] [Abstract][Full Text] [Related]
10. Effect of Anagliptin and Sitagliptin on Low-Density Lipoprotein Cholesterol in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: Rationale and Study Design of the REASON Trial.
Ueda S; Shimabukuro M; Arasaki O; Node K; Nomiyama T; Morimoto T
Cardiovasc Drugs Ther; 2018 Feb; 32(1):73-80. PubMed ID: 29435776
[TBL] [Abstract][Full Text] [Related]
11. Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: a subgroup analysis of the PROLOGUE study.
Yamada H; Tanaka A; Kusunose K; Amano R; Matsuhisa M; Daida H; Ito M; Tsutsui H; Nanasato M; Kamiya H; Bando YK; Odawara M; Yoshida H; Murohara T; Sata M; Node K;
Cardiovasc Diabetol; 2017 May; 16(1):63. PubMed ID: 28490337
[TBL] [Abstract][Full Text] [Related]
12. Impact of type 2 diabetes on serial changes in tissue characteristics of coronary plaques: an integrated backscatter intravascular ultrasound analysis.
Inaba S; Okayama H; Funada J; Higashi H; Saito M; Yoshii T; Hiasa G; Sumimoto T; Takata Y; Nishimura K; Inoue K; Ogimoto A; Higaki J
Eur Heart J Cardiovasc Imaging; 2012 Sep; 13(9):717-23. PubMed ID: 22368195
[TBL] [Abstract][Full Text] [Related]
13. Treatment with statin on atheroma regression evaluated by intravascular ultrasound with Virtual Histology (TRUTH Study): rationale and design.
Nozue T; Yamamoto S; Tohyama S; Umezawa S; Kunishima T; Sato A; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Sozu T; Michishita I;
Circ J; 2009 Feb; 73(2):352-5. PubMed ID: 19110505
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled Trial.
Oyama J; Murohara T; Kitakaze M; Ishizu T; Sato Y; Kitagawa K; Kamiya H; Ajioka M; Ishihara M; Dai K; Nanasato M; Sata M; Maemura K; Tomiyama H; Higashi Y; Kaku K; Yamada H; Matsuhisa M; Yamashita K; Bando YK; Kashihara N; Ueda S; Inoue T; Tanaka A; Node K;
PLoS Med; 2016 Jun; 13(6):e1002051. PubMed ID: 27351380
[TBL] [Abstract][Full Text] [Related]
15. Dipeptidyl peptidase-4 inhibitor sitagliptin improves pancreatic β-cell function in hypertensive diabetic patients treated with angiotensin receptor blockers.
Fukui K; Kawahito H; Wakana N; Kikai M; Terada K; Yamamoto K; Irie D; Kato T; Miyagawa S; Yamada H
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1001-9. PubMed ID: 26195265
[TBL] [Abstract][Full Text] [Related]
16. Effect of dipeptidyl peptidase-4 inhibitor in patients undergoing bypass surgery.
Ogawa S; Okawa Y; Sawada K; Goto Y; Fukaya S; Suzuki T
Asian Cardiovasc Thorac Ann; 2016 Nov; 24(9):863-867. PubMed ID: 27784818
[TBL] [Abstract][Full Text] [Related]
17. Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial.
Hirohata A; Yamamoto K; Miyoshi T; Hatanaka K; Hirohata S; Yamawaki H; Komatsubara I; Murakami M; Hirose E; Sato S; Ohkawa K; Ishizawa M; Yamaji H; Kawamura H; Kusachi S; Murakami T; Hina K; Ohe T
J Am Coll Cardiol; 2010 Mar; 55(10):976-82. PubMed ID: 20202514
[TBL] [Abstract][Full Text] [Related]
18. Asymptomatic coronary artery disease in a Norwegian cohort with type 2 diabetes: a prospective angiographic study with intravascular ultrasound evaluation.
Arora S; Ofstad AP; Ulimoen GR; Birkeland KI; Endresen K; Gullestad L; Johansen OE
Cardiovasc Diabetol; 2019 Mar; 18(1):26. PubMed ID: 30851727
[TBL] [Abstract][Full Text] [Related]
19. Sitagliptin and cardiovascular outcomes in diabetic patients with chronic kidney disease and acute myocardial infarction: A nationwide cohort study.
Chen DY; Wang SH; Mao CT; Tsai ML; Lin YS; Chou CC; Wen MS; Wang CC; Hsieh IC; Hung KC; Chen TH
Int J Cardiol; 2015 Feb; 181():200-6. PubMed ID: 25528312
[TBL] [Abstract][Full Text] [Related]
20. DPP-4 inhibition ameliorates atherosclerosis by priming monocytes into M2 macrophages.
Brenner C; Franz WM; Kühlenthal S; Kuschnerus K; Remm F; Gross L; Theiss HD; Landmesser U; Kränkel N
Int J Cardiol; 2015 Nov; 199():163-9. PubMed ID: 26197403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
